SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-016012
Filing Date
2022-11-02
Accepted
2022-11-02 16:31:01
Documents
51
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q edit-20220930x10q.htm   iXBRL 10-Q 1591457
2 EX-31.1 edit-20220930xex31d1.htm EX-31.1 15590
3 EX-31.2 edit-20220930xex31d2.htm EX-31.2 15024
4 EX-32.1 edit-20220930xex32d1.htm EX-32.1 10101
  Complete submission text file 0001558370-22-016012.txt   5608141

Data Files

Seq Description Document Type Size
5 EX-101.SCH edit-20220930.xsd EX-101.SCH 24349
6 EX-101.CAL edit-20220930_cal.xml EX-101.CAL 40075
7 EX-101.DEF edit-20220930_def.xml EX-101.DEF 119562
8 EX-101.LAB edit-20220930_lab.xml EX-101.LAB 300010
9 EX-101.PRE edit-20220930_pre.xml EX-101.PRE 207292
45 EXTRACTED XBRL INSTANCE DOCUMENT edit-20220930x10q_htm.xml XML 1070781
Mailing Address 11 HURLEY ST. CAMBRIDGE MA 02141
Business Address 11 HURLEY ST. CAMBRIDGE MA 02141 617-401-9000
Editas Medicine, Inc. (Filer) CIK: 0001650664 (see all company filings)

IRS No.: 464097528 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37687 | Film No.: 221354611
SIC: 2836 Biological Products, (No Diagnostic Substances)